Emerging Diseases News

Hospitalized patients with multisystem inflammatory syndrome in children — or MIS-C —are far more likely to experience shock than those hospitalized with Kawasaki disease, according to a study.

BOSTON — Boosting with mRNA-1273 provided additional COVID-19 protection during the delta and omicron waves, and especially among older adults, according to data from the phase 3 coronavirus efficacy (COVE) trial presented at IDWeek.

BOSTON — Expanded use of wastewater surveillance confirmed spikes in clinical cases of COVID-19, influenza and respiratory syncytial virus in one of Canada’s largest cities, according to study findings presented at IDWeek.

BOSTON — Two doses of an experimental live-attenuated intranasal COVID-19 vaccine generated a robust immune response in a phase 1 trial, researchers reported.

IDWeek relaxed its COVID-19 policies this year, no longer requiring that attendees wear a mask or provide proof of vaccination.

An NIH-funded study found a potential link between the combination of prenatal COVID-19 and maternal stress and an increased risk for impaired attention span in infants, according to findings reported in Pediatric Research.

Enhanced infection prevention and control efforts during COVID-19 reduced the rates of some hospital infections at a comprehensive cancer center, including Clostridioides difficile and multidrug-resistant infections, according to a study.

NEW YORK — Children that contracted COVID-19 are at risk for developing multisystem inflammatory syndrome, which can present cutaneously, according to a poster presentation here.

Out-of-hospital cardiac arrests rose by 19% during the COVID-19 pandemic in King County, Washington, yet data suggest pandemic-related changes in emergency medical services response and care — not the virus itself — affected survival.

Half of patients with long COVID demonstrate persistent inflammation and may potentially benefit from immunomodulation, according to data.